Lord, Abbett & Co. LLC Danaher Corp Transaction History

Lord, Abbett & Co. LLC

  • $30.7 Billion
  • Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Danaher Corp stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 939,335 shares of DHR stock, worth $222 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
939,335
Previous 853,496 10.06%
Holding current value
$222 Million
Previous $213 Million 22.47%
% of portfolio
0.85%
Previous 0.7%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$239.25 - $280.76 $20.5 Million - $24.1 Million
85,839 Added 10.06%
939,335 $261 Million
Q2 2024

Oct 07, 2024
BUY
$235.51 - $267.98 $36.8 Million - $41.9 Million
156,425 Added 22.44%
853,496 $213 Million
Q2 2024

Aug 14, 2024
BUY
$235.51 - $267.98 $36.8 Million - $41.9 Million
156,425 Added 22.44%
853,496 $213 Million
Q1 2024

Oct 07, 2024
BUY
$224.58 - $256.19 $31.9 Million - $36.4 Million
142,152 Added 25.62%
697,071 $174 Million
Q1 2024

May 09, 2024
BUY
$224.58 - $256.19 $31.9 Million - $36.4 Million
142,152 Added 25.62%
697,071 $174 Million
Q4 2023

Oct 07, 2024
BUY
$185.1 - $233.13 $6.94 Million - $8.74 Million
37,483 Added 7.24%
554,919 $128 Million
Q4 2023

Feb 12, 2024
BUY
$185.1 - $233.13 $6.94 Million - $8.74 Million
37,483 Added 7.24%
554,919 $128 Million
Q2 2023

Oct 07, 2024
BUY
$224.99 - $256.14 $63.2 Million - $72 Million
280,905 Added 118.76%
517,436 $124 Million
Q2 2023

Aug 14, 2023
BUY
$224.99 - $256.14 $63.2 Million - $72 Million
280,905 Added 118.76%
517,436 $124 Million
Q1 2023

Oct 07, 2024
SELL
$239.75 - $277.0 $24 Million - $27.7 Million
-99,996 Reduced 29.71%
236,531 $59.6 Million
Q1 2023

May 12, 2023
SELL
$239.75 - $277.0 $24 Million - $27.7 Million
-99,996 Reduced 29.71%
236,531 $59.6 Million
Q4 2022

Oct 07, 2024
SELL
$241.42 - $282.29 $125 Million - $146 Million
-516,969 Reduced 60.57%
336,527 $89.3 Million
Q4 2022

Feb 10, 2023
BUY
$241.42 - $282.29 $19.8 Million - $23.2 Million
82,191 Added 32.32%
336,527 $89.3 Million
Q3 2022

Nov 14, 2022
BUY
$247.06 - $1507.4 $6.87 Million - $41.9 Million
27,825 Added 12.28%
254,336 $65.7 Million
Q2 2022

Aug 12, 2022
SELL
$237.11 - $299.66 $55.3 Million - $69.9 Million
-233,105 Reduced 50.72%
226,511 $57.4 Million
Q1 2022

May 13, 2022
BUY
$257.27 - $315.76 $68 Million - $83.4 Million
264,278 Added 135.29%
459,616 $135 Million
Q4 2021

Feb 11, 2022
SELL
$292.08 - $329.01 $916,839 - $1.03 Million
-3,139 Reduced 1.58%
195,338 $64.3 Million
Q3 2021

Nov 09, 2021
SELL
$272.21 - $332.43 $11.1 Million - $13.6 Million
-40,950 Reduced 17.1%
198,477 $60.4 Million
Q2 2021

Aug 11, 2021
SELL
$225.08 - $271.69 $42.2 Million - $51 Million
-187,573 Reduced 43.93%
239,427 $64.3 Million
Q1 2021

May 11, 2021
SELL
$212.38 - $245.9 $23.6 Million - $27.3 Million
-111,189 Reduced 20.66%
427,000 $96.1 Million
Q4 2020

Feb 09, 2021
SELL
$212.5 - $245.46 $5 Million - $5.78 Million
-23,548 Reduced 4.19%
538,189 $120 Million
Q3 2020

Nov 12, 2020
SELL
$177.16 - $215.33 $2.74 Million - $3.33 Million
-15,475 Reduced 2.68%
561,737 $121 Million
Q2 2020

Aug 14, 2020
BUY
$128.7 - $176.83 $14.2 Million - $19.5 Million
110,516 Added 23.68%
577,212 $102 Million
Q1 2020

May 14, 2020
BUY
$121.39 - $169.05 $31.4 Million - $43.8 Million
258,912 Added 124.61%
466,696 $64.6 Million
Q4 2019

Feb 14, 2020
SELL
$133.47 - $153.48 $9.23 Million - $10.6 Million
-69,155 Reduced 24.97%
207,784 $31.9 Million
Q3 2019

Nov 14, 2019
BUY
$135.4 - $146.47 $8.7 Million - $9.41 Million
64,249 Added 30.21%
276,939 $40 Million
Q2 2019

Aug 14, 2019
BUY
$124.88 - $143.73 $26.6 Million - $30.6 Million
212,690 New
212,690 $30.4 Million

Others Institutions Holding DHR

# of Institutions
2,508
Shares Held
542M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email